The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Administering Daratumumab

Posted: Thursday, December 14, 2017

When you treat patients with their first dose of daratumumab, what is the protocol for pre- and post-medication in your myeloma program?



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.